Ribomic (TSE:4591) Valuation Rank


TSE:4591 Ribomic Inc TSE:4591
30 GF Score
Price 円59.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ribomic Valuation Rank Related Terms

TSE:4591
30GF Score
Ribomic Inc TSE:4591
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
30GF Score

Get the complete analysis for TSE:4591

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円59.00
Price